Market Place
Sourcing Support
Biovie To Present Abstract At 2026 Aan Annual Meeting
14 Apr 2026 //
GLOBENEWSWIRE
Biovie Announces Abstract Accepted For Presentation At AD/PD 2026
12 Mar 2026 //
GLOBENEWSWIRE
BioVie Wraps Phase 2 SUNRISE-PD Enrollment for Parkinson
08 Jan 2026 //
GLOBENEWSWIRE
Biovie Hosts Live Investor Webinar On December 9
19 Nov 2025 //
GLOBENEWSWIRE
BioVie Explores Bezisterim for COVID Neurological Symptoms Trial
13 Aug 2025 //
GLOBENEWSWIRE
BioVie Announces Pricing of $12 Million Public Offering
07 Aug 2025 //
GLOBENEWSWIRE
BioVie Reveals Bezisterim`s Potential Age Deceleration Advantage
24 Jul 2025 //
GLOBENEWSWIRE
BioVie`s Bezisterim Data on Slows Aging at World Aging Conference
09 Jul 2025 //
GLOBENEWSWIRE
BioVie Enrolls First Patient in ADDRESS-LC Trial for Long Covid
15 May 2025 //
GLOBENEWSWIRE
BioVie Reveals Advisory Board with Neuralink Co-Founder
05 May 2025 //
GLOBENEWSWIRE
BioVie starts SUNRISE-PD trial for early Parkinson Disease
16 Apr 2025 //
GLOBENEWSWIRE
BioVie To Present Phase 2 Study Design Of Bezisterim For Long COVID
20 Nov 2024 //
GLOBENEWSWIRE
BioVie’s Parkinson’s Disease Trial Fully Funded
04 Nov 2024 //
GLOBENEWSWIRE
BioVie Inc. Announces Closing of Registered Direct Offering
29 Oct 2024 //
GLOBENEWSWIRE
BioVie Inc. Closes Registered Direct Offering And Placement
24 Oct 2024 //
GLOBENEWSWIRE
BioVie Live Investor Webinar and Q&A on November 7
23 Oct 2024 //
GLOBENEWSWIRE
BioVie Inc. Prices Registered Direct Offering Under Nasdaq Rules
23 Oct 2024 //
GLOBENEWSWIRE
BioVie Receives Notice Of Allowance For Japan Patent Application
15 Oct 2024 //
GLOBENEWSWIRE
BioVie Receives Patent Allowance for Liquid Terlipressin Formulation
01 Oct 2024 //
GLOBENEWSWIRE
BioVie Inc. Announces Closing of Public Offering
25 Sep 2024 //
GLOBENEWSWIRE
BioVie Announces FDA Approval for Phase 2 Long COVID Trial of Bezisterim
03 Sep 2024 //
GLOBENEWSWIRE
BioVie Presents Bezisterim Data At Aging Research And Drug Discovery Meeting
27 Aug 2024 //
GLOBENEWSWIRE
BioVie To Present Bezisterim Data At Aging Research Conference
13 Aug 2024 //
GLOBENEWSWIRE
BioVie Announces Formation of Advisory Board for Bezisterim in Long COVID
04 Jun 2024 //
GLOBENEWSWIRE
BioVie Awarded Up to $13.1M DoD Funding for Long COVID Bezisterim
29 Apr 2024 //
GLOBENEWSWIRE
BioVie`s Bezisterim Reduces Inflammation, AD Biomarkers
25 Apr 2024 //
GLOBENEWSWIRE
BioVie blames trial site exclusions for failed Alzheimer`s drug study
30 Nov 2023 //
GLOBENEWSWIRE
BioVie Issues Letter to Shareholders
18 Jul 2023 //
GLOBENEWSWIRE
BioVie Presents Data Showing How NE3107 May Potentially Regulate DNA Methylation
17 Jul 2023 //
GLOBENEWSWIRE
BioVie to Present Data Showing How NE3107 Regulates DNA Methylation of Genes
10 Jul 2023 //
GLOBENEWSWIRE
BioVie Presents Data Highlighting Role of Insulin Resistance & Neuroinflammation
26 Jun 2023 //
GLOBENEWSWIRE
